A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer*.
Rothenberg, M. L.; Moore, M. J.; Cripps, M. C.; Andersen, J. S.; Portenoy, R. K.; Burriss, H. A.; Green, M. R.; Tarassoff, P. G.; Brown, T. D.; Casper, E. S.; Storniolo, A.-M.; Von Hoff, D. D.; Annals of Oncology, 1996, vol. 7, issue 4, p 347, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef